Seeing Is Believing
IBRX is currently covered by 6 analysts with an average price target of $11.67. This is a potential upside of $4.67 (31.57%) from yesterday's end of day stock price of $8.87.
Immunitybio's activity chart (see below) currently has 30 price targets and 43 ratings on display. The stock rating distribution of IBRX is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 75.45% with an average time for these price targets to be met of 269.75 days.
Highest price target for IBRX is $23, Lowest price target is $7, average price target is $11.67.
Most recent stock forecast was given by from D. BORAL CAPITAL on 05-May-2026. First documented stock forecast 24-Aug-2015.
Currently out of the existing stock ratings of IBRX, 18 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 20-Jan-2026
$23
$14.29 (164.06%)
$23
2 months 4 days ago
(05-May-2026)
0/10 (0%)
$15.42 (203.43%)
Buy Since 04-Mar-2026
$12
$3.29 (37.77%)
$5
4 months 5 days ago
(04-Mar-2026)
1/2 (50%)
$3 (33.33%)
241
Buy Since 06-Mar-2025
$10
$1.29 (14.81%)
$8
5 months 13 days ago
(26-Jan-2026)
8/8 (100%)
$3.79 (61.03%)
253
Buy Since 10-Jan-2025
$9
$0.29 (3.33%)
$6
5 months 16 days ago
(23-Jan-2026)
3/3 (100%)
$2.55 (39.53%)
220
Buy Since 20-Jan-2026
$7
$-1.71 (-19.63%)
$4.25
5 months 19 days ago
(20-Jan-2026)
7/11 (63.64%)
$0.52 (8.02%)
92
What is IBRX (Immunitybio) average time for price targets to be met?
Which analyst has the current highest performing score on IBRX (Immunitybio) with a proven track record?
Which analyst has the most public recommendations on IBRX (Immunitybio)?
Which analyst is the currently most bullish on IBRX (Immunitybio)?
Which analyst is the currently most reserved on IBRX (Immunitybio)?